Website intended for a NZ health professional readership
Pseudoephedrine became available for over-the-counter sale for the first time in 13 years on 20 May, after the ACT Party delivered on its election promise to undo the 2011 reclassification of the product as a prescription-only medicine. Jonathan Chilton-Towle looks at what pharmacies have experienced since then
Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā
Not a subscriber? Unlock this article by subscribing here.
Academic pharmacist Nataly Martini discusses the medical management of asthma in adults and adolescents, which has evolved to prioritise early anti-inflammatory treatment. She also explains how to improve patient outcomes by proactively identifying poor asthma control and supporting equitable access to education and treatment
Ever heard these myths from smokers?
